[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368552-105":59,"doc-detail-368552-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-prognostic-and-predictive-value-of-homologous-recombination-deficiency-in-gastrointestinal-cancer","The prognostic and predictive value of homologous recombination deficiency in gastrointestinal cancer","","The homologous recombination (HR) system repairs DNA double-strand breaks via a signaling network anchored by BRCA1/2 and other DNA repair proteins including ATM, PALB2, BARD1, RAD51, and Fanconi anemia factors. Genetic mutations and epigenetic changes in HR genes can cause homologous recombination deficiency (HRD), driving genomic instability and supporting the development of solid tumors. While BRCA1/2 mechanisms are well established, evidence for other HR genes remains limited; HRD may be better captured by the HRD score combining loss of heterozygosity, LST, and TAI. This review summarizes HRD pathogenesis and predictive value in digestive system tumors, focusing on platinum drugs, PARP inhibitors, and immunotherapy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-prognostic-and-predictive-value-of-homologous-recombination-deficiency-in-gastrointestinal-cancer/368552/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-prognostic-and-predictive-value-of-homologous-recombination-deficiency-in-gastrointestinal-cancer/368552.png","ImageObject",300,407,{"name":92,"@type":93},"Sarah ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is homologous recombination deficiency (HRD) in gastrointestinal cancer?","Question",{"text":112,"@type":113},"HRD refers to germline or somatic variants and epigenetic silencing of HR-related genes, leading to impaired, unstable DNA double-strand break repair. In gastrointestinal cancer, it occurs at a certain rate among tumors and is clinically relevant.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is HRD measured more accurately than using HR gene variation alone?",{"text":117,"@type":113},"HRD is often defined by HR-related gene variation, but newer studies indicate that the HRD score—combining loss of heterozygosity, LST, and TAI—better reflects genomic instability.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is HRD important for treatment selection in digestive system tumors?",{"text":121,"@type":113},"HRD is associated with sensitivity to platinum-based drugs and PARP inhibitors and may increase tumor immunogenicity. It can therefore help predict outcomes, guide targeted therapy and immunotherapy, and support early screening of high-risk populations.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368552,1790196413,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962085320529,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","The prognostic and predictive value of homologous recombination deficiency in gastrointestinal cancer  \nBeibei Jiang1,2, Yile Shang1, Xiang Zhang2, Wenguang He3, Hanju Hua1, Feng Ye1, Xile Zhou1, Yandong Li1, Weixiang Zhong4, Weiqin Jiang*, 1, Guosheng Wu*, 1,  \n1Department of Colorectal Surgery, The First Affiliated Hospital, Zhejiang University, Hangzhou 310003, China, 2College of Medicine, Zhejiang University, Hangzhou 310058, China,  \n3Department of Radiology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China, 4Department of Pathology, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China  \n* Corresponding authors. Guosheng Wu, Department of Colorectal Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou 310003, [China. E-mail:](China. E-mail: guosheng_wu@zju.edu.cn)[ guosheng_wu@zju.edu.cn](China. E-mail: guosheng_wu@zju.edu.cn); Weiqin Jiang, Department of Colorectal Surgery, The First Affiliated Hospital, Zhejiang  \nUniversity School of Medicine, 79 Qingchun Road, Hangzhou 310003, [China. E-mail:](China. E-mail: weiqinjiang@zju.edu.cn)[ weiqinjiang@zju.edu.cn](China. E-mail: weiqinjiang@zju.edu.cn).  \nAbstract  \nThe homologous recombination (HR) system repairs DNA double-strand breaks produced by the DNA damage response, which is a complex signaling pathway consisting of the key proteins BRCA1/2 and other DNA repair proteins, such as the ATM, PALB2, BARD1, RAD51, and Fanconi anemia proteins. Mutations and epigenetic alterations in HR-related genes may lead to homologous recombination deficiency (HRD), resulting in genomic instability and contributing to the development of certain solid tumors. The biological significance and molecular mechanism of BRCA1/2 mutation-related HRD are well understood, but the relationships of other HR-related genes and their variant forms with HRD have not been sufficiently studied. These genes exhibit multiple forms of variation, including one or more HR genes, germline or somatic mutations, monoallelic or biallelic variants, and not all variants present HRD. Therefore, HRD is usually defined as HR-related gene variation, but recent studies have shown that defining it as the combined score of loss of heterozygosity, LST and TAI, known as the HRD score, can more accurately assess genomic instability. In patients with HRD, platinum-based therapy and poly ADP-ribose polymerase enzyme inhibitor (PARPi) have been shown to perform well in ovarian, breast, and prostate cancers. For gastrointestinal cancer (GI cancer), HRD has been relatively well studied in pancreatic cancer, but its role in other cancers has rarely been reported. Herein, we review the pathogenesis and predictive value of HRD, including the use of platinum drugs, PARPi, and immunotherapy, in digestive system tumors.  \nKey words: homologous recombination deficiency (HRD); HR-related genes; platinum sensitivity; poly ADP-ribose polymerase enzyme inhibitor (PARPi); gastrointestinal cancer (GI cancer) .  \nImplications for Practice  \nHomologous recombination deficiency (HRD) occurs at a certain rate in gastrointestinal tumors. There is substantial evidence confirming that HRD is associated with the sensitivity to platinum-based drugs and PARP inhibitors in patients with ovarian, breast, prostate, and pancreatic cancers. This deficiency may also increase the immunogenicity of tumor cells, allowing them to benefit from immunotherapy, and it may link to poorer prognosis. Analyzing of HRD in gastrointestinal tumors can better predict outcomes, guide targeted therapies and immunotherapies, and facilitate early screening of high-risk populations, which is of great importance for improving clinical practice.  \nIntroduction  \nHomologous recombination deficiency (HRD) refers to the germline or somatic variants and epigenetic silencing of homologous recombination (HR)-related genes, resulting in the absence of stabl","cbCaiaMazQhreW6v","https://ap.wps.com/l/cbCaiaMazQhreW6v","pdf",732022,"English","# Abstract\n# Implications for Practice\n# Introduction","[{\"question\":\"What is homologous recombination deficiency (HRD) in gastrointestinal cancer?\",\"answer\":\"HRD refers to germline or somatic variants and epigenetic silencing of HR-related genes, leading to impaired, unstable DNA double-strand break repair. In gastrointestinal cancer, it occurs at a certain rate among tumors and is clinically relevant.\"},{\"question\":\"How is HRD measured more accurately than using HR gene variation alone?\",\"answer\":\"HRD is often defined by HR-related gene variation, but newer studies indicate that the HRD score—combining loss of heterozygosity, LST, and TAI—better reflects genomic instability.\"},{\"question\":\"Why is HRD important for treatment selection in digestive system tumors?\",\"answer\":\"HRD is associated with sensitivity to platinum-based drugs and PARP inhibitors and may increase tumor immunogenicity. It can therefore help predict outcomes, guide targeted therapy and immunotherapy, and support early screening of high-risk populations.\"}]","The prognostic and predictive value of homologous recombination deficiency in gastrointestinal cancer | PDF",1790177467,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e272bc210ffff1223fd41c135693a58e.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8e5575e228af2bfe6381b2e6533a2a18.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8cacf7ce1058cb354a88a4be049b28b1.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14b40d4aff949dcb45d6f5ac497c3b04.webp",980,1287]